Filed with ASX · · 5 pages · English
The program has led to significant reductions in poorly controlled diabetes and improvements in blood pressure control among patients. Vitasora's approach combines behavioral science with clinical support to engage patients in their health management. The company aims to expand its clinical capacity and patient enrollment while targeting cash-flow breakeven in the near future.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ASX ANNOUNCEMENT ASX:VHL th 9 November 2026 Vitasora CCM Patients Continue to Outperform National Benchmarks, Strengthening US Growth Opportunities Highlights • Better results, and still improving: Patients in Vitasora’s CCM program, delivered in partnership with the physicians and care teams...
Vitasora Health Limited on 6ix
Follow Vitasora Health into a list and get an email when it puts out news.
Follow Vitasora Health